ABCB1 variant provides important leads for pharmacogenetics of epilepsy
Phani, M.N.; Satyamoorthy, K.
Journal of Postgraduate Medicine 60(3): 239-240
2014
ISSN/ISBN: 0022-3859 PMID: 25272393 Document Number: 677289
Document emailed within 1 workday
Related Documents
Axelson, H.; Panda, C.K.; Silva, S.; Sugiyama, H.; Wiener, F.; Klein, G.; Sumegi, J. 1991: A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda Oncogene 6(12): 2263-2270Zappoli, R.; Schergna, E. 1955: Basal leads in temporal epilepsy; electro-anatomoclinical aspects Rassegna di Studi Psichiatrici 44(5): 625-673
Chackalamannil, S.; Desai, M.C. 2007: Identifying quality leads - an important factor in reducing attrition of clinical candidates Current Opinion in Drug Discovery and Development 10(4): 381-382
Kukla, P.; Jastrzebski, M.; Bacior, B.ła.; Gomuła, P.; Grodecki, J.; Kawecka-Jaszcz, K. 2007: Variant Brugada syndrome--mild ST segment elevation in inferior leads and aborted sudden cardiac death Kardiologia Polska 65(12): 1494-1498
Helten, A.; Marschall, M.; Reininger, A.J.; Meier-Ewert, H. 1996: Experimental infection with a persistent influenza C virus variant leads to prolonged genome detection in the chicken lung Acta Virologica 40(4): 223-226
Mar'enko, L.B. 1985: "Rolandic" variant of opercular epilepsy Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 85(10): 1486-1490
Calo, A.A. 1975: The triad secondary R waves, RS-T segment elevation and T waves inversion in right precordial leads: a normal electrocardiographic variant Giornale Italiano di Cardiologia 5(6): 955-960
1973: Asbestos leads to lung cancer leads to mesothelioma Lancet 1(7807): 815-816
Sánchez-Alvarez, J.C.; Altuzarra-Corral, A.; Mercadé-Cerdá, J.M.; Casado-Chocán, J.L.; Moreno-Alegre, V.; Rufo-Campos, M.; Camino-León, R.; Galán-Barranco, J.M.; Pita-Calandre, E.; Ramos-Lizana, J.; Serrano-Castro, P.J. 2005: The Andalusia Epilepsy Society's Guide to Epilepsy Therapy 2005: IV. General principles of antiepileptic polytherapy and therapeutic strategies in refractory epilepsy Revista de Neurologia 40(12): 743-750
Grezes-Rueff, C.; Rascol, A.; Ribaut, L. 1956: Visceral epilepsy; abdominal epilepsy and pseudo-angina epilepsy Toulouse Medical 57(10): 883-892
Jörgensen, G. 1979: What is pharmacogenetics? Therapie der Gegenwart 118(5): 699
Lamy, M. 1972: Pharmacogenetics La Nouvelle Presse Medicale 1(46): 3103-3106
Somerville, E.R.; Antony, J.H. 1995: Position statement on the use of rectal diazepam in epilepsy. Epilepsy Society of Australia, the Child Neurology Study Group, the Australian Association of Neurologists, and the National Epilepsy Association of Australia Medical Journal of Australia 163(5): 268-269
Rodríguez-Nóvoa, S.; Barreiro, P.; Jiménez-Nacher, I.; Rendón, A.; Soriano, V. 2005: Pharmacogenetics in HIV therapy Aids Reviews 7(2): 103-112
Smith, M.W.; Mendoza, R.P. 1996: Ethnicity and pharmacogenetics Mount Sinai Journal of Medicine new York 63(5-6): 285-290
Weinshilboum, R.M. 1984: Human pharmacogenetics: Introduction Federation Proceedings 43(8): 2295-2297
Furukori, N. 2010: Clinical pharmacogenetics in the treatment of schizophrenia Nihon Shinkei Seishin Yakurigaku Zasshi 30(2): 65-69
Brinker, R.R.; Ranganathan, P. 2010: Methotrexate pharmacogenetics in rheumatoid arthritis Clinical and Experimental Rheumatology 28(5 Suppl 61: S33-S39
Juli, G.; Juli, L. 2016: Pharmacogenetics: does a personal therapy exist? Psychiatria Danubina 28(Suppl-1): 141-144
Lanfear, D.E.; McLeod, H.L. 2007: Pharmacogenetics: using DNA to optimize drug therapy American Family Physician 76(8): 1179-1182